Local Institution - 0239

Osaka 541-8567

1 studies enrolling now · 2 studies all time

What they study most

Acute Ischemic Stroke, Breast Neoplasms, Transient Ischemic Attack (TIA)

Studies at this site

• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel — Completed